INS and Hyperglycemia: Following DSS exposure, wild-type BALB/c and C57BL/6 mice display increased levels of circulating RELMα, whereas RELMα-deficient mice are distinctly protected from DSS-induced colitis and glucose injection-induced hyperglycemia independent of changes in insulin levels.